Clinical Trials Logo

Clinical Trial Summary

This is a prospective international multi-center registry and biorepository trial of children and adolescents/young adults (AYA) undergoing hematopoietic cell transplantation (HCT) to assess the impact of endotheliopathies in the HCT setting as a contributor of significant morbidity and mortality.


Clinical Trial Description

Primary: - To evaluate the proportion of pediatric patients undergoing hematopoietic cell transplant (HCT) who develop endotheliopathies (SOS, TMA, DAH and IPS) and/or MODS within 100 days of such therapies. - To evaluate the proportion of pediatric patients undergoing hematopoietic cell transplant (HCT) who experience abnormal levels of circulating angiogenic, vascular permeability and inflammatory factors within 100 days post HCT-CT in the setting of endotheliopathies. Secondary/Exploratory Objective(s): - To determine the impact of endotheliopathies in the HCT setting on the overall survival. - To assess the efficacy of specific prophylaxis and treatment strategies directed at endotheliopathies (SOS, TMA, DAH and IPS) post-HCT among enrolled children on overall survival. - To assess whether exposure to immunotherapies (CAR-T, PD-1 Inhibitors, bispecific T-cell engager (BiTE) antibodies and antibody drug conjugates) prior to HCT affects post-HCT outcomes (endotheliopathies and MODS). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05090345
Study type Observational
Source Duke University
Contact LaTarsha Spencer
Phone (919) 613-1895
Email latarsha.spencer@duke.edu
Status Recruiting
Phase
Start date November 19, 2019
Completion date February 5, 2026

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03179761 - High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients Phase 2
Recruiting NCT05634512 - Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in Patients With Mucopolysaccharidosis Type IH.
Completed NCT05600101 - Development and Piloting an Avatar-based Intervention to Support Patients Undergoing Stem Cell Transplantation N/A
Recruiting NCT05866302 - Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
Completed NCT04139577 - FMT In High-Risk Acute GVHD After ALLO HCT Phase 1
Completed NCT04727827 - Pharmacogenomic-Guided Supportive Care in Hematopoietic Cell Transplantation N/A